EVP-ABD-enhanced MRI to evaluate diffuse liver disease in a rat model.
EVP-ABD-enhanced MRI to evaluate diffuse liver disease in a rat model.
复制标题
EVP-ABD 增强 MRI 评估大鼠模型中的弥漫性肝病。
DOI:
10.1002/jmri.21385
复制
发表时间:
2008
期刊:
影响因子:
--
通讯作者:
Renshaw,PerryF
中科院分区:
文献类型:
--
作者:
Zuo,ChunS;Seoane,PeterR;Thomsen,Morgane;Gillis,Tim;Meloni,Edward;Harnish,PhillipP;Renshaw,PerryF
PurposeTo evaluate the feasibility of using manganese‐based MR imaging contrast agent EVP‐ABD to detect diffuse liver disease in an established rat hepatitis model.Materials and MethodsHepatitis was induced by administration of CCl4in corn oil vehicle to rats intraperitoneally. MR images were acquired on a 3T scanner using a volume coil ≈36 hours after the administration of CCl4. EVP‐ABD was administered via a tail vein at a dose of 10 μmol/kg. Multi‐TI turboflash images were acquired to evaluate liver R1 (=1/T1) values before and after the EVP‐ABD administration. Eighteen rats received various doses of CCl4and completed pre‐ and postcontrast MRI scans and liver histologic evaluation.ResultsThe liver R1 after the EVP‐ABD administration and the change of the liver R1 before and after the administration, ΔR1, show significant correlations with the CCl4dose. A significant correlation was also found between the histologic scores and the CCl4doses despite known variability in the relationship of CCl4dose to histology. A significant correlation was found between the histologic score and ΔR1.ConclusionOur results indicate that EVP‐ABD‐enhanced MRI can detect diffuse liver disease generated by CCl4based on the significant correlation between proton R1 in liver following EVP‐ABD and the CCl4doses as well as the histologic scores. J. Magn. Reson. Imaging 2008;27:1317–1321. © 2008 Wiley‐Liss, Inc.